Lee T S
Department of Anesthesiology, Harbor-UCLA Medical Center, Torrance 90509-2910.
Br J Anaesth. 1994 Aug;73(2):225-6. doi: 10.1093/bja/73.2.225.
Acetazolamide, a carbonic anhydrase inhibitor, may cause significant disturbances in carbon dioxide transport and elimination. In this study, end-tidal carbon dioxide monitoring has been used to study the correlation between arterial carbon dioxide (PaCO2) and end-tidal carbon dioxide partial pressure (PE'CO2) in rabbits treated with acetazolamide. A significant difference in (PaCO2-PE'CO2) developed immediately after administration of acetazolamide and persisted for more than 2 h. It is concluded that PE'CO2 did not reflect accurately PaCO2 and the ventilatory status of the rabbit which received acetazolamide within 2 h.
乙酰唑胺是一种碳酸酐酶抑制剂,可能会导致二氧化碳运输和消除方面的显著紊乱。在本研究中,呼气末二氧化碳监测已被用于研究用乙酰唑胺治疗的兔子动脉二氧化碳(PaCO2)与呼气末二氧化碳分压(PE'CO2)之间的相关性。在给予乙酰唑胺后立即出现(PaCO2-PE'CO2)的显著差异,并持续超过2小时。得出的结论是,在2小时内接受乙酰唑胺治疗的兔子中,PE'CO2不能准确反映PaCO2和通气状态。